No Data
No Data
Has Krystal Biotech, Inc.'s (NASDAQ:KRYS) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Unusual Options Activity: X, WMT and Others Attract Market Bets, X V/OI Ratio Reaches 666.7
Here's Why Krystal Biotech, Inc. (KRYS) Is a Strong Momentum Stock
Insider Sale: President of $KRYS Sells 6,514 Shares